Ayurvedic treatment for prostate enlargement

A randomised controlled clinical study to evaluate the efficacy of vastyamayantaka ghrita uttara basti in the management of vatashteela(Benign prostatic hyperplasia) - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105524

Enrollment

Registered

2026-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N400- Benign prostatic hyperplasia without lower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient with signs and symptoms of Vatashteela (Benign Prostatic Hyperplasia) and IPSS (International Prostate Symptom Score ) less than 19. Patient with age group between 50 t o 80 years. USG o f Abdomen and pelvis prostate suggestive o f increased weight upto 80gm Patient who willing t o give written Informed consent were included in the study.

Exclusion criteria

Exclusion criteria: Patients with malignancy of prostate will be excluded. Patients with severe urinary tract infection, urethral stricture will be excluded. Patients with severe cardio vascular, renal or hepatic disorders. Hypertension (more than 160 100mmHg) & Diabetes mellitus (RBS more than 250mgdl) are excluded. Patients with immune compromised diseases will be excluded. Patients with US findings suggestive of Hydroureteronephrosis are excluded. PSA valuve more than 4ngdl

Design outcomes

Primary

Measure	Time frame
1 Size of prostate 2 Post Void Residual volume (PVR) 3 Incomplete emptying 4 Frequency 5 Intermittency 6 Urgency 7 Weak stream 8 Straining 9 Nocturia the above mentioned symptoms will be reduced after the studyTimepoint: Assessment days 10th 20th 30th day according to IPSS or AUASI scale Follow up on 60th day Total study duration is 60 days	—

Secondary

Measure	Time frame
1 Size of prostate 2 Post Void Residual volume (PVR) 3 Incomplete emptying 4 Frequency 5 Intermittency 6 Urgency 7 Weak stream 8 Straining 9 Nocturia The above mentioned symptoms will be reduced after the study & the patient will be relievedTimepoint: The Assessment days are on 10th 20th 30th day Follow up on 60th day Total study duration is 60 days according to IPSS or AUASI scale	—

Countries

India

Contacts

Public ContactDr Lohit kalal

Shri Jagadguru Gavisiddeshwar Ayurvedic Medical College Koppal

dr.lohitkalal7108@gmail.com7090116108

Outcome results